T. Field

发表

TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

J. Perkins, A. Mishra, J. Lancet, 2017, Clinical lymphoma, myeloma & leukemia.

Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models.

J. Perkins, J. Lancet, Ling Zhang, 2013, Leukemia research.

Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications

J. Perkins, J. Pidala, Jongphil Kim, 2011, International journal of hematology.

Role and Timing of Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

C. Anasetti, T. Field, 2010, Mediterranean journal of hematology and infectious diseases.

Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome

J. Perkins, J. Lancet, E. Padron, 2011 .

Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation

J. Perkins, J. Greene, R. Sandin, 2006, Bone Marrow Transplantation.

Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease

J. Perkins, J. Pidala, C. Anasetti, 2010, Bone Marrow Transplantation.

Infliximab for managing steroid-refractory acute graft-versus-host disease.

J. Perkins, J. Pidala, Jongphil Kim, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sirolimus for treatment of steroid-refractory acute graft-versus-host disease

J. Perkins, J. Pidala, Jongphil Kim, 2010, Bone Marrow Transplantation.

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation

J. Pidala, A. Mishra, Jongphil Kim, 2017, Haematologica.

Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review.

Ling Zhang, E. Sotomayor, J. Cultrera, 2011, Leukemia research.

Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population

J. Greene, M. Kharfan-Dabaja, R. Sandin, 2009, International journal of hematology.

276 Outcome of azacitidine treatment of patients with therapy related myelodysplastic syndrome

J. Perkins, J. Lancet, Luxi Zhang, 2011 .

Voriconazole Provides Effective Prophylaxis for Invasive Fungal Infection in Patients Receiving Glucocorticoid Therapy for Graft-Versus-Host Disease

M. Schell, J. Perkins, C. Anasetti, 2009, Bone Marrow Transplantation.

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

J. Perkins, J. Pidala, Jongphil Kim, 2011, Haematologica.

Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity

J. Perkins, J. Pidala, Jongphil Kim, 2011, Bone Marrow Transplantation.

ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation.

J. Perkins, J. Pidala, C. Anasetti, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hypoalbuminemia at Day +90 Is Associated with Inferior Nonrelapse Mortality and Overall Survival in Allogeneic Hematopoietic Cell Transplantation Recipients: A Confirmatory Study.

J. Pidala, C. Anasetti, F. Locke, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for myelofibrosis: A 10‐year experience at single institution

J. Perkins, J. Pidala, Jongphil Kim, 2010, American journal of hematology.

Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allografting.

J. Perkins, J. Pidala, J. Pinilla-Ibarz, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids

J. Perkins, J. Pidala, C. Anasetti, 2011, Haematologica.

Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience

J. Perkins, J. Pidala, A. Mishra, 2015, Bone Marrow Transplantation.

Pretransplantation 5-azacitidine in high-risk myelodysplastic syndrome.

J. Perkins, A. Mishra, J. Lancet, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

H. Jim, J. Perkins, J. Pidala, 2012, Haematologica.

A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis.

J. Perkins, W. Janssen, D. Sullivan, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

J. Perkins, J. Pidala, Jongphil Kim, 2010, Journal of hematology & oncology.

Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission

J. Perkins, J. Pidala, C. Anasetti, 2014, Bone Marrow Transplantation.

Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantation.

J. Perkins, D. Sullivan, J. Pidala, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes

L. Shaw, J. Perkins, C. Anasetti, 2011, Bone Marrow Transplantation.

Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemia.

J. Perkins, W. Janssen, J. Pidala, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.

J. Pidala, A. Mishra, Jongphil Kim, 2015, Biology of Blood and Marrow Transplantation.

Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease

H. Jim, J. Pidala, A. Mishra, 2015, Haematologica.

Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease

J. Pidala, A. Mishra, C. Anasetti, 2018, Bone Marrow Transplantation.

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation

H. Jim, J. Pidala, A. Mishra, 2017, Haematologica.

Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.

Daohai Yu, J. Perkins, J. Lancet, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes.

J. Perkins, J. Pidala, Jongphil Kim, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation

J. Perkins, W. Janssen, D. Sullivan, 2010, Bone Marrow Transplantation.

Administration of Rituximab Is Feasible and Does Not Affect Engraftment of Allograft Recipients with Advanced CD20+ Malignancies.

J. Perkins, D. Sullivan, L. Brand, 2007 .

Busulfan Area-under-the-Curve Finding Study within a Busulfan/Fludarabine (BuFlu) Conditioning Regimen before Allogeneic Hematopoietic Cell Transplantation (HCT).

J. Perkins, W. Janssen, C. Anasetti, 2006 .

Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization

M. Schell, J. Perkins, J. Pidala, 2013, Bone Marrow Transplantation.

A Randomized, Controlled Trial of Graft-Versus-Host Disease (GVHD) Prophylaxis Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate: Analysis of GVHD, Relapse and Survival

M. Schell, J. Perkins, Jongphil Kim, 2009 .

Sirolimus/Tacrolimus Facilitates Preferential Recovery of Regulatory T Cells (Treg) After Allogeneic Hematopoietic Cell Transplantation (HCT), and Is More Effective Than Methotrexate/Tacrolimus in Preventing Grade II-IV Acute Graft Vs. Host Disease (GVHD) and Moderate to Severe Chronic Gvhd

H. Jim, J. Perkins, J. Pidala, 2011 .

Are matched unrelated donor transplants justified for AML in CR1?

J. Perkins, C. Anasetti, M. Nieder, 2006, Best practice & research. Clinical haematology.

Targeted Intravenous Busulfan Combined with Fludarabine (tBuFlu) as Conditioning Prior to Allogeneic Peripheral Blood Stem Cell Transplant: Early Results of Low Treatment Related Mortality.

J. Perkins, W. Janssen, C. Anasetti, 2005 .

Patient Ethnicity Markedly Affects The Probability Of Finding An HLA-A, -B, -C, And DRB1 Allele Matched Unrelated Donor For Hemopoietic Cell Transplantation

C. Anasetti, H. Fernandez, D. Confer, 2010 .

Retrospective Comparison Of Secondary Mobilization Strategies In Candidates For Autologous Hematopoietic Cell Transplantion With A Focus On Resource Utilization: Plerixafor+G-CSF Versus Other Regimens

J. Perkins, K. Daily, C. Anasetti, 2010 .

Coping strategies modify risk of depression associated with hematopoietic cell transplant symptomatology

S. Sutton, H. Jim, P. Jacobsen, 2018, Journal of health psychology.

Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients.

M. Fishman, S. Sutton, H. Jim, 2016, Journal of psychosomatic research.

Pre-Transplant 5-Azacitidine (Vidaza®) May Improve Outcome of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Myelodysplastic Syndrome (MDS).

J. Perkins, W. Janssen, C. Anasetti, 2006 .

New sources for argument: do HLA-C and HLA disparity in adult double umbilical cord blood transplants predict outcomes?

J. Pidala, C. Anasetti, H. Fernandez, 2016, Bone Marrow Transplantation.

Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with Autologous Stem Cell Transplant in Refractory Cancer: Pharmacokinetic and Pharmacodynamic Correlates

J. Perkins, D. Sullivan, Jongphil Kim, 2011, Clinical Cancer Research.

Validation of the Newly Proposed MD Anderson Prognostic Risk Model for Patients with Myelodysplastic Syndromes

J. Lancet, E. Padron, A. List, 2010 .

Adult anaplastic large cell lymphoma involving the central nervous system: a rare clinical scenario

M. Bui, Ling Zhang, J. Caracciolo, 2011, Annals of Hematology.

Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.

J. Pidala, A. Mishra, Jongphil Kim, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allografting.

J. Perkins, J. Pidala, J. Pinilla-Ibarz, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Coping strategies modify risk of depression associated with hematopoietic cell transplant symptomatology

S. Sutton, H. Jim, P. Jacobsen, 2018, Journal of health psychology.